ARL15

ARL15 is a small GTPase that functions at the Golgi apparatus and plasma membrane to regulate cargo trafficking, magnesium ion transport, and TGF-β/Smad signaling. Triple S-acylation at Cys17/Cys22/Cys23, mediated by the Golgi-resident acyltransferases ZDHHC7 and ZDHHC3, is required for ARL15 membrane association and Golgi localization; loss of palmitoylation redistributes ARL15 to the cytosol and disrupts selective cargo sorting, including caveolin-2 and STX6 (PMID:41999893, PMID:40241309). ARL15 binds CNNM magnesium transporters via their CBS domains, promotes their complex N-glycosylation, and thereby inhibits Mg²⁺ transport in competition with PRL phosphatases, as revealed by a crystal structure of the ARL15–CNNM2 complex and mutagenesis of the key contact residue R95 (PMID:34089346, PMID:37449820). In TGF-β signaling, GTP-bound ARL15 binds the Smad4 MH2 domain at endolysosomes to relieve Smad4 autoinhibition and promote Smad complex assembly, with Smad4 itself acting as a GAP that discharges ARL15 upon complex formation (PMID:35834310). ARL15 is essential for adipocyte differentiation and adiponectin secretion, and global knockout in mice causes postnatal lethality with complete cleft palate (PMID:29242557, PMID:37773757).

1. 2017 Medium

   The initial functional characterization established that ARL15 acts at the Golgi to regulate adipocyte-specific secretory trafficking, answering whether GWAS-associated ARL15 had a direct cellular role in adiponectin biology.

   Evidence siRNA knockdown in differentiated 3T3-L1 adipocytes showing impaired adiponectin secretion; GFP-tagging revealing Golgi/plasma membrane/vesicle localization

   PMID:29242557

   Open questions at the time

   • Mechanism linking ARL15 Golgi function to adiponectin secretion unknown
   • No cargo specificity defined beyond adiponectin
   • No in vivo validation
2. 2021 High

   Discovery that ARL15 directly binds CNNM magnesium transporters and promotes their complex N-glycosylation identified the first effector pathway, establishing ARL15 as a negative regulator of cellular Mg²⁺ transport.

   Evidence Co-IP of ARL15–CNNM2, co-localization in kidney ER/Golgi/plasma membrane, N-glycosylation assays, and ²⁵Mg²⁺ uptake measurements with siRNA knockdown

   PMID:34089346

   Open questions at the time

   • Structural basis of ARL15–CNNM interaction not yet resolved
   • Relative contribution of glycosylation vs. direct channel regulation unclear
   • In vivo relevance to renal Mg²⁺ homeostasis not tested
3. 2021 Medium

   Demonstration that ARL15 is palmitoylated and that this modification governs its Golgi localization answered how a soluble small GTPase achieves membrane association, while identifying ARL6IP5 as an interacting partner.

   Evidence Palmitoylation assay and confocal microscopy in mouse liver and human adipocytes; palmitoylation-deficient mutant redistributes to cytoplasm; Co-IP/mass spectrometry

   PMID:34779483

   Open questions at the time

   • Specific palmitoylated cysteines not mapped
   • Enzymes responsible for palmitoylation not identified
   • Functional role of ARL6IP5 interaction unknown
4. 2022 High

   Identification of Smad4 as both an effector and a GAP for ARL15 revealed a GTPase-regulated mechanism for TGF-β/Smad complex assembly, showing how ARL15 relieves Smad4 autoinhibition at endolysosomes.

   Evidence Co-IP, co-localization, GTPase activity assays, dominant-negative/constitutively-active mutants, TGF-β reporter assays

   PMID:35834310

   Open questions at the time

   • Structural basis of ARL15–Smad4 MH2 interaction not resolved
   • How ARL15 is recruited to endolysosomes unknown
   • Physiological context (which TGF-β target genes) not defined
5. 2023 High

   The crystal structure of ARL15 in complex with the CNNM2 CBS-pair domain provided atomic-level understanding of the interaction and revealed that ARL15 and PRL phosphatases compete for the same CNNM binding site, establishing antagonistic regulation of ion transport.

   Evidence X-ray crystallography, R95A mutagenesis abolishing CNNM binding and Mg²⁺/Zn²⁺ transport inhibition, competitive binding assays with PRL2

   PMID:37449820

   Open questions at the time

   • In vivo competition between ARL15 and PRL at CNNMs not demonstrated
   • Role of GTP/GDP cycling in CNNM regulation not fully integrated
   • No structure of ternary ARL15–CNNM–PRL complex
6. 2023 Medium

   Biochemical and SAXS characterization of ARL15 revealed measurable GTPase enzymatic activity and nucleotide-dependent conformational extension of the N-terminal region, providing a biophysical framework for understanding how lipid modification and nucleotide state regulate ARL15 function.

   Evidence Spectroscopy-based GTPase assays and small-angle X-ray scattering in solution

   PMID:37939768

   Open questions at the time

   • SAXS envelope is low resolution; N-terminal dynamics not confirmed by high-resolution methods
   • Relevance of measured Km/Vmax to cellular GTP concentrations not discussed
   • GEF and GAP (beyond Smad4) not identified
7. 2023 Medium

   Global Arl15 knockout in mice established an essential in vivo role, with postnatal lethality and complete cleft palate demonstrating that ARL15 is required for craniofacial morphogenesis and cell migration.

   Evidence CRISPR/Cas9 germline knockout mice; cell migration assays in MEFs

   PMID:37773757

   Open questions at the time

   • Mechanism linking ARL15 GTPase activity to palatal shelf fusion unknown
   • Conditional tissue-specific knockouts not performed
   • Whether cleft palate reflects TGF-β pathway disruption or trafficking defects not determined
8. 2025 Medium

   Identification of selective Golgi cargo mislocalization (caveolin-2, STX6) upon ARL15 depletion, together with enhanced cell spreading and adhesion, defined ARL15 as a cargo-selective Golgi trafficking regulator with downstream effects on cell-substrate mechanics.

   Evidence siRNA depletion and dominant-negative mutant expression in HeLa cells; traction force microscopy, focal adhesion quantification

   PMID:40241309

   Open questions at the time

   • Whether caveolin-2/STX6 are direct ARL15 effector cargoes or indirect targets unknown
   • Molecular link between cargo mistrafficking and enhanced adhesion not established
   • Contribution to cleft palate phenotype not tested
9. 2026 High

   Mapping of triple S-acylation to Cys17/Cys22/Cys23 and identification of ZDHHC7/ZDHHC3 as the responsible acyltransferases resolved how ARL15 achieves membrane association, completing the palmitoylation mechanism.

   Evidence APEGS assays, Cys-to-Ser mutagenesis of all three sites, siRNA and CRISPR disruption of ZDHHC enzymes, subcellular fractionation, confocal imaging in HEK293T cells

   PMID:41999893

   Open questions at the time

   • Whether dynamic palmitoylation cycling regulates ARL15 activity not addressed
   • Thioesterase(s) mediating depalmitoylation unknown
   • How palmitoylation cooperates with GTP/GDP cycling for membrane targeting not defined

• The GEF(s) activating ARL15, the full spectrum of effectors beyond CNNM and Smad4, and the mechanistic link between ARL15-dependent cargo trafficking and developmental phenotypes (cleft palate, adipogenesis) remain to be established.
• No GEF identified
• Whether CNNM regulation and Smad4 signaling represent independent or interconnected ARL15 functions unknown
• Tissue-specific conditional models needed to dissect developmental vs. metabolic roles